Zacharon Pharmaceuticals Raises $3.5M

San Diego-based Zacharon Pharmaceutical said today that it has raised $3.5M in a Series A financing for the firm's biopharmaceuticals technology. According to the firm, the financing came from Avalon Ventures LLC. The firm also said it has received more than $2.2M in National Institutes of Health (NIH) research grants. Zacharon Pharmaceutical is developing glycan inhibitors which have appications in treating genetic disorders and oncology. More information »